The Valley Desk

NCT01272258 · Interventional trial

A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence

Overall registry status Withdrawn

Phase 2

Conditions HIV

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov